Dopamine agonists for hyperprolactinaemia

  • Protocol
  • Intervention

Authors

  • Paula Lustoza Gomes,

    Corresponding author
    1. Secretaria Municipal de Saúde (Municipal Health Department), Farmácia Municipal (Municipal Pharmacy), Volta Redonda, Rio de Janeiro, Brazil
    • Paula Lustoza Gomes, Farmácia Municipal (Municipal Pharmacy), Secretaria Municipal de Saúde (Municipal Health Department), Rua 566, 31, Nossa Senhora das Graças, Volta Redonda, Rio de Janeiro, 27.295-390, Brazil. paula.lustoza@gmail.com.

    Search for more papers by this author
  • Vania S Nunes,

    1. Botucatu Medical School - State University/Unesp, Department of Internal Medicine, São Paulo, São Paulo, Brazil
    Search for more papers by this author
  • Álvaro N Atallah,

    1. Universidade Federal de São Paulo / Escola Paulista de Medicina, Brazilian Cochrane Centre, São Paulo, SP, Brazil
    Search for more papers by this author
  • Edina MK da Silva

    1. Universidade Federal de São Paulo, Emergency Medicine and Evidence Based Medicine, São Paulo, São Paulo, Brazil
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of dopamine agonists for hyperprolactinaemia.